Figure 1.
EPO attenuates OVA-induced hallmarks of the asthma. (A) Experimental schematic for OVA sensitization, inhalation challenge, and EPO treatment. (B, C) RI (B) and Cdyn (C) in response to increasing doses of methacholine. (D) Percentage of eosinophils in BALF. *p<0.05. N=10. Statistics: one-way ANOVA with a Bonferroni Correction.